LncRNA CCAT1/miR-130a-3p axis increases cisplatin resistance in non-small-cell lung cancer cell line by targeting SOX4

References

• Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62:10–29. doi:10.3322/caac.20138.
   PubMed Web of Science ®Google Scholar
• Ardizzoni A, Boni L, Tiseo M, Fossella FV, Schiller JH, Paesmans M, Radosavljevic D, Paccagnella A, Zatloukal P, Mazzanti P, et al. Cisplatin- versus carboplatin-based chemotherapy in first-line treatment of advanced non-small-cell lung cancer: an individual patient data meta-analysis. J Natl Cancer Inst. 2007;99:847–57. doi:10.1093/jnci/djk196.
   PubMed Web of Science ®Google Scholar
• Barabas K, Milner R, Lurie D, Adin C. Cisplatin: a review of toxicities and therapeutic applications. Vet Comp Oncol. 2008;6:1–18. doi:10.1111/j.1476-5829.2007.00142.x.
   PubMed Web of Science ®Google Scholar
• Ren K, Li Y, Lu H, Li Z, Li Z, Wu K, Li Z, Han X. Long Noncoding RNA HOTAIR Controls Cell Cycle by Functioning as a Competing Endogenous RNA in Esophageal Squamous Cell Carcinoma. Transl Oncol. 2016;9:489–97. doi:10.1016/j.tranon.2016.09.005.
   PubMed Web of Science ®Google Scholar
• Jalali S, Bhartiya D, Lalwani MK, Sivasubbu S, Scaria V. Systematic transcriptome wide analysis of lncRNA-miRNA interactions. PloS one. 2013;8:e53823. doi:10.1371/journal.pone.0053823.
   PubMed Web of Science ®Google Scholar
• Juan L, Wang G, Radovich M, Schneider BP, Clare SE, Wang Y, Liu Y. Potential roles of microRNAs in regulating long intergenic noncoding RNAs. BMC Med Genomics. 2013;6:S7. doi:10.1186/1755-8794-6-S1-S7.
   PubMed Web of Science ®Google Scholar
• Wang Y, Liu Z, Yao B, Dou C, Xu M, Xue Y, Ding L, Jia Y, Zhang H, Li Q, et al. Long non-coding RNATUSC7acts a molecular sponge for miR-10a and suppresses EMT in hepatocellular carcinoma. Tumor Biol. 2016;37:11429–41. doi:10.1007/s13277-016-4892-6.
   PubMedGoogle Scholar
• Zhen L, Yun-Hui L, Hong-Yu D, Jun M, Yi-Long Y. Long noncoding RNA NEAT1 promotes glioma pathogenesis by regulating miR-449b-5p/c-Met axis. Tumor Biol. 2016;37:673–83. doi:10.1007/s13277-015-3843-y.
   PubMedGoogle Scholar
• Yang F, Xue X, Bi J. Long noncoding RNA CCAT1, which could be activated by c-Myc, promotes the progression of gastric carcinoma. J Cancer Res Clin Oncol. 2013;139:437–45. doi:10.1007/s00432-012-1324-x.
   PubMed Web of Science ®Google Scholar
• Liang D, Yang SB, Xu FF, Zhang JH. Long noncoding RNA CCAT1 promotes hepatocellular carcinoma progression by functioning as let-7 sponge. J Exp Clin Cancer Res. 2015;34:18. doi:10.1186/s13046-015-0136-7.
   PubMed Web of Science ®Google Scholar
• Chen J, Zhang K, Song H, Wang R, Chu X, Chen L. Long noncoding RNA CCAT1 acts as an oncogene and promotes chemoresistance in docetaxel-resistant lung adenocarcinoma cells. Oncotarget. 2016;7:62474–89. doi:10.18632/oncotarget.11518.
   PubMed Web of Science ®Google Scholar
• Gregory RI, Chendrimada TP, Cooch N, Shiekhattar R. Human RISC Couples MicroRNA Biogenesis and Posttranscriptional Gene Silencing. Cell. 2005;123:631–40. doi:10.1016/j.cell.2005.10.022.
   PubMed Web of Science ®Google Scholar
• Peng F, Zhang H, Du Y, Tan P. miR-23a promotes cisplatin chemoresistance and protects against cisplatin-induced apoptosis in tongue squamous cell carcinoma cells through Twist. Oncol Rep. 2014;33:942–50. doi:10.3892/or.2014.3664.
   PubMed Web of Science ®Google Scholar
• Yashiro M, Nishii T, Hasegawa T, Matsuzaki T, Morisaki T, Fukuoka T, Hirakawa K. A c-Met inhibitor increases the chemosensitivity of cancer stem cells to the irinotecan in gastric carcinoma. Br J Cancer. 2013;109:2619–28. doi:10.1038/bjc.2013.638.
   PubMed Web of Science ®Google Scholar
• Hou Z, Xu C, Xie H, Xu H, Zhan P, Yu L, Fang X. Long Noncoding RNAs Expression Patterns Associated with Chemo Response to Cisplatin Based Chemotherapy in Lung Squamous Cell Carcinoma Patients. Plos One. 2014;9:e108133. doi:10.1371/journal.pone.0108133.
   PubMed Web of Science ®Google Scholar
• Li Z, Zhao X, Zhou Y, Liu Y, Zhou Q, Ye H, Wang YX, Zeng J, Song Y, Gao W, et al. The long non-coding RNA HOTTIP promotes progression and gemcitabine resistance by regulating HOXA13 in pancreatic cancer. J Transl Med. 2015;13:84. doi:10.1186/s12967-015-0442-z.
   PubMed Web of Science ®Google Scholar
• Liu J, Wan L, Lu K, Sun M, Pan X, Zhang P, Lu B, Liu G, Wang Z. The Long Noncoding RNA MEG3 Contributes to Cisplatin Resistance of Human Lung Adenocarcinoma. PloS one. 2015;10:e0114586. doi:10.1371/journal.pone.0114586.
   PubMed Web of Science ®Google Scholar
• Johnsson P, Ackley A, Vidarsdottir L, Lui WO, Corcoran M, Dan G, Morris KV. A pseudogene long-noncoding-RNA network regulates PTEN transcription and translation in human cells. Nat Struct Mol Biol. 2013;20:440–6. doi:10.1038/nsmb.2516.
   PubMed Web of Science ®Google Scholar
• Yokoyama Y, Wan X, Shinohara A, Takahashi S, Takahashi Y, Niwa K, Tamaya T. Expression of PTEN and PTEN pseudogene in endometrial carcinoma. Int J Mol Med. 2000;6:47–50.
   PubMed Web of Science ®Google Scholar
• Zhu H, Zhou X, Chang H, Li H, Liu F, Ma C, Lu J. CCAT1 promotes hepatocellular carcinoma cell proliferation and invasion. Int J Clin Exp Pathol. 2015;8:5427–34.
   PubMed Web of Science ®Google Scholar
• Ma MZ, Chu BF, Zhang Y, Weng MZ, Qin YY, Gong W, Quan ZW. Long non-coding RNA CCAT1 promotes gallbladder cancer development via negative modulation of miRNA-218-5p. Cell Death Dis. 2015;6:e1583. doi:10.1038/cddis.2014.541.
   PubMed Web of Science ®Google Scholar
• Lv L, Jia JQ, Chen J. LncRNA CCAT1 Upregulates Proliferation and Invasion in Melanoma Cells Via Suppressing miR-33a. Oncol Res. 2017; doi:10.3727/096504017X14920318811749.
   Google Scholar
• Wang Q, Zhang W, Hao S. LncRNA CCAT1 modulates the sensitivity of paclitaxel in nasopharynx cancers cells via miR-181a/CPEB2 axis. Cell Cycle. 16:795–801. doi:10.1080/15384101.2017.1301334.
   PubMed Web of Science ®Google Scholar
• Li N, Yang L, Wang H, Yi T, Jia X, Chen C, Xu P. MiR-130a and MiR-374a Function as Novel Regulators of Cisplatin Resistance in Human Ovarian Cancer A2780 Cells. Plos One. 2015;10:e0128886. doi:10.1371/journal.pone.0128886.
   PubMed Web of Science ®Google Scholar
• Yang L, Li N, Wang H, Jia X, Wang X, Luo J. Altered microRNA expression in cisplatin-resistant ovarian cancer cells and upregulation of miR-130a associated with MDR1/P-glycoprotein-mediated drug resistance. Oncol Rep. 2012;28:592–600. doi:10.3892/or.2012.1823.
   PubMed Web of Science ®Google Scholar
• Zhang XA, Huang L, Zhao Y, Tan W. Downregulation of miR-130a contributes to cisplatin resistance in ovarian cancer cells by targeting X-linked inhibitor of apoptosis (XIAP) directly. Acta Biochim Biophys Sin (Shanghai). 2013;45:995–1001. doi:10.1093/abbs/gmt113.
   PubMed Web of Science ®Google Scholar
• Zhou YM, Liu J, Sun W. MiR-130a Overcomes Gefitinib Resistance by Targeting Met in Non-Small Cell Lung Cancer Cell Lines. Asian Pac J Cancer Prev. 2014;15:1391–6.
   PubMedGoogle Scholar
• Fujita Y, Kojima T, Kawakami K, Mizutani K, Kato T, Deguchi T, Ito M. miR‐130a activates apoptotic signaling through activation of caspase‐8 in taxane‐resistant prostate cancer cells. Prostate. 2015;75:1568–78. doi:10.1002/pros.23031.
   PubMed Web of Science ®Google Scholar
• Xu N, Shen C, Luo Y, Xia L, Xue F, Xia Q, Zhang J. Upregulated miR-130a increases drug resistance by regulating RUNX3 and Wnt signaling in cisplatin-treated HCC cell. Biochem Biophys Res Commun. 2012;425:468–72. doi:10.1016/j.bbrc.2012.07.127.
   PubMed Web of Science ®Google Scholar
• Schepers GE, Teasdale RD, Koopman P. Twenty pairs of sox: extent, homology, and nomenclature of the mouse and human sox transcription factor gene families. Dev Cell. 2002;3:167–70.
   PubMed Web of Science ®Google Scholar
• Penzo-Méndez AI. Critical roles for SoxC transcription factors in development and cancer. Int J Biochem Cell Biol. 2010;42:425–8. doi:10.1016/j.biocel.2009.07.018.
   PubMed Web of Science ®Google Scholar
• Kang M, Li Y, Liu W, Wang R, Tang A, Hao H, Liu Z, Ou H. miR-129-2 suppresses proliferation and migration of esophageal carcinoma cells through downregulation of SOX4 expression. Int J Mole Med. 2013;32:51–8. doi:10.3892/ijmm.2013.1384.
   PubMed Web of Science ®Google Scholar
• Li Y, Zu L, Wang Y, Wang M, Chen P, Zhou Q. miR-132 inhibits lung cancer cell migration and invasion by targeting SOX4. J Thorac Dis. 2015;7:1563–9. doi:10.3978/j.issn.2072-1439.2015.09.06.
   PubMed Web of Science ®Google Scholar
• Zhang J, Liang Q, Lei Y, Yao M, Li L, Gao X, Feng J, Zhang Y, Gao H, Liu DX, et al. SOX4 induces epithelial-mesenchymal transition and contributes to breast cancer progression. Cancer Res. 2012;72:4597–608. doi:10.1158/0008-5472.CAN-12-1045.
   PubMed Web of Science ®Google Scholar
• Sun R, Jiang B, Qi H, Zhang X, Yang J, Duan J, Li Y, Li G. SOX4 contributes to the progression of cervical cancer and the resistance to the chemotherapeutic drug through ABCG2. Cell Death Dis. 2015;6:e1990. doi:10.1038/cddis.2015.290.
   PubMed Web of Science ®Google Scholar
• Ke SZ, Ni XY, Zhang YH, Wang YN, Wu B, Gao FG. Camptothecin and cisplatin upregulate ABCG2 and MRP2 expression by activating the ATM/NF-κB pathway in lung cancer cells. Int J Oncol. 2013;42:1289–96. doi:10.3892/ijo.2013.1805.
   PubMed Web of Science ®Google Scholar